Literature DB >> 24037221

Design and testing of paramagnetic liposome-based CEST agents for MRI visualization of payload release on pH-induced and ultrasound stimulation.

Daniela Delli Castelli1, Cinzia Boffa, Pierangela Giustetto, Enzo Terreno, Silvio Aime.   

Abstract

The development of nanomedicines in cancer therapy is constantly growing because of the advantages associated with the use of nanosized drug delivery systems. Among them, the possibility of accurate spatiotemporal control of the release of the chemotherapeutic from the carrier is one of the most interesting and clinically relevant. To further improve the therapy outcome, the clinical translation of imaging protocols for the in vivo visualization of the release step is of paramount importance. In this work, the combination of the great chemical versatility of liposomes and the outstanding potential of MRI chemical exchange saturation transfer agents has been successfully harnessed to image the selective release of the liposomal content stimulated by endogenous (variation of pH) and externally applied (nonfocused ultrasound) stimuli. The use of clinically safe components (both liposomes and MRI agents) and the good results obtained in vitro hold promise for a successful future in vivo translation.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24037221     DOI: 10.1007/s00775-013-1042-0

Source DB:  PubMed          Journal:  J Biol Inorg Chem        ISSN: 0949-8257            Impact factor:   3.358


  28 in total

Review 1.  Advancement in multifunctional nanoparticles for the effective treatment of cancer.

Authors:  Mahfoozur Rahman; Mohammad Zaki Ahmad; Imran Kazmi; Sohail Akhter; Muhammad Afzal; Gaurav Gupta; Farhan Jalees Ahmed; Firoz Anwar
Journal:  Expert Opin Drug Deliv       Date:  2012-03-08       Impact factor: 6.648

Review 2.  Functionalized nanosystems for targeted mitochondrial delivery.

Authors:  Shelley A Durazo; Uday B Kompella
Journal:  Mitochondrion       Date:  2011-11-23       Impact factor: 4.160

3.  Highly sensitive MRI chemical exchange saturation transfer agents using liposomes.

Authors:  Silvio Aime; Daniela Delli Castelli; Enzo Terreno
Journal:  Angew Chem Int Ed Engl       Date:  2005-08-26       Impact factor: 15.336

4.  How to determine free Gd and free ligand in solution of Gd chelates. A technical note.

Authors:  Alessandro Barge; Giancarlo Cravotto; Eliana Gianolio; Franco Fedeli
Journal:  Contrast Media Mol Imaging       Date:  2006 Sep-Oct       Impact factor: 3.161

5.  Numerical solution of the Bloch equations provides insights into the optimum design of PARACEST agents for MRI.

Authors:  Donald E Woessner; Shanrong Zhang; Matthew E Merritt; A Dean Sherry
Journal:  Magn Reson Med       Date:  2005-04       Impact factor: 4.668

Review 6.  Image-guided nanosystems for targeted delivery in cancer therapy.

Authors:  A K Iyer; J He; M M Amiji
Journal:  Curr Med Chem       Date:  2012       Impact factor: 4.530

7.  Improved paramagnetic liposomes for MRI visualization of pH triggered release.

Authors:  Elena Torres; Francesco Mainini; Roberta Napolitano; Franco Fedeli; Roberta Cavalli; Silvio Aime; Enzo Terreno
Journal:  J Control Release       Date:  2011-05-20       Impact factor: 9.776

8.  Imaging in vivo extracellular pH with a single paramagnetic chemical exchange saturation transfer magnetic resonance imaging contrast agent.

Authors:  Guanshu Liu; Yuguo Li; Vipul R Sheth; Mark D Pagel
Journal:  Mol Imaging       Date:  2012-02       Impact factor: 4.488

9.  Chemical exchange saturation transfer (CEST): what is in a name and what isn't?

Authors:  Peter C M van Zijl; Nirbhay N Yadav
Journal:  Magn Reson Med       Date:  2011-02-17       Impact factor: 4.668

10.  Is combination therapy the next step to overcome resistance and reduce toxicities in melanoma?

Authors:  C M Nijenhuis; J B A G Haanen; J H M Schellens; J H Beijnen
Journal:  Cancer Treat Rev       Date:  2012-12-01       Impact factor: 12.111

View more
  7 in total

Review 1.  Stimuli-responsive liposomes for drug delivery.

Authors:  Y Lee; D H Thompson
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2017-02-15

2.  Contrast agents for MRI: 30+ years and where are we going?

Authors:  Valérie C Pierre; Matthew J Allen; Peter Caravan
Journal:  J Biol Inorg Chem       Date:  2014-01-11       Impact factor: 3.358

3.  Liposomal Fe(III) Macrocyclic Complexes with Hydroxypropyl Pendants as MRI Probes.

Authors:  Samira M Abozeid; Md Saiful I Chowdhury; Didar Asik; Joseph A Spernyak; Janet R Morrow
Journal:  ACS Appl Bio Mater       Date:  2021-10-15

Review 4.  Nanoplatforms for Targeted Stimuli-Responsive Drug Delivery: A Review of Platform Materials and Stimuli-Responsive Release and Targeting Mechanisms.

Authors:  Yuzhe Sun; Edward Davis
Journal:  Nanomaterials (Basel)       Date:  2021-03-16       Impact factor: 5.076

5.  MRI Contrast Agents for Pharmacological Research.

Authors:  Enzo Terreno; Silvio Aime
Journal:  Front Pharmacol       Date:  2015-12-09       Impact factor: 5.810

Review 6.  Nanogels as imaging agents for modalities spanning the electromagnetic spectrum.

Authors:  Minnie Chan; Adah Almutairi
Journal:  Mater Horiz       Date:  2015-10-19       Impact factor: 13.266

Review 7.  Sonosensitive MRI Nanosystems as Cancer Theranostics: A Recent Update.

Authors:  Francesca Garello; Enzo Terreno
Journal:  Front Chem       Date:  2018-05-07       Impact factor: 5.221

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.